Genetic associations with measles PRNT and IgG antibody response to MMR vaccination in 6- and 15-month-old children
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Hans and Nora Buchards Fund
- King Christian X Fund
- Ville Heises Legat
- Dagmar Marshall Fund
- Innovation Fund Denmark
This publication has 32 references indexed in Scilit:
- Comparison of measles plaque reduction neutralization test (PRNT) and measles virus-specific IgG ELISA for assessment of immunogenicity of measles-mumps-rubella vaccination at 5–7 months of age and maternal measles antibodiesVaccine: X, 2024
- Immunogenicity and reactogenicity following MMR vaccination in 5–7-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infantseClinicalMedicine, 2024
- Sex and age as determinants of the seroprevalence of anti-measles IgG among European healthcare workers: A systematic review and meta-analysisVaccine, 2022
- Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccineHuman Genetics, 2017
- Heritability of vaccine-induced measles neutralizing antibody titersVaccine, 2017
- The concept of vaccination failureVaccine, 2012
- MeaslesThe Lancet, 2012
- Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newbornsVaccine, 2007
- Twin studies of immunogenicity — determining the genetic contribution to vaccine failureVaccine, 2001
- Measles Reimmunization in Children Seronegative After Initial ImmunizationJAMA, 1997